Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a maintenance update to the document or site component. This reflects an internal change rather than an alteration to user-facing content.
    Difference
    0.1%
    Check dated 2026-05-14T23:09:54.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page shows a revision tag updated to v3.5.3, replacing the previous v3.5.2. This reflects a minor update to the ClinicalTrials.gov entry without altering core study information.
    Difference
    0.1%
    Check dated 2026-04-30T16:15:10.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:34.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Screenshots show no visible additions or deletions; page content appears unchanged between versions.
    Difference
    0.1%
    Check dated 2026-04-02T04:52:34.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A new site revision v3.5.0 has been added and the older revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:25:54.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    - Page template revision updated from v3.4.2 to v3.4.3. This is a metadata/update that does not affect study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-03-11T18:12:46.000Z thumbnail image

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.